GlassScriptPhysician profile
Sarah R Greene
NPI 1083868582
$3,610.73
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,289 · 2022: $1,001 · 2023: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $531.47 | 2021-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $461.47 | 2021-2023 | Brilinta |
| Amgen INC. | $325.92 | 2021-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $318.54 | 2021-2023 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $316.56 | 2021-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $300.83 | 2021-2022 | |
| Pfizer INC. | $273.64 | 2021-2022 | |
| Esperion Therapeutics, INC. | $257.02 | 2021-2022 | |
| Boston Scientific Corporation | $149.43 | 2021 | |
| Abbott Laboratories | $143.09 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.28 | 2021-2023 | Jardiance, Stiolto Respimat |
| Sanofi-Aventis U.S. LLC | $102.49 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $97.58 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.75 | 2021 | |
| Arbor Pharmaceuticals, INC. | $53.08 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $35.70 | 2021 | |
| Exeltis, USA INC. | $23.51 | 2023 | Slynd |
| Lilly USA, LLC | $13.52 | 2023 | Taltz |
| Alnylam Pharmaceuticals INC. | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.